Transmeta has agreed to sell its Crusoe line of processors to Hong Kong based Culturecom Technology for USD 15 million. The deal also involves the licensing of 130-nanometer Efficeon technology. Production of both chips had already been ceased by Transmeta as the company decided to focus on its newer 90 nm Efficeon. Culturecom will pay royalties over sales of Crusoe and Efficeon products. If approved by American authorities, the transaction is expected to close by December.